Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration and the Risk of Stroke: A 5-Year Follow-up Cohort Study

被引：0
|
作者：
Kim, Sung Soo [1 ]
Rim, Tyler Hyungtaek [1 ]
Lee, Christopher Seungkyu [1 ]
Lee, SungChul [1 ]
Kim, Do Wook [1 ]
Park, Hyun Ju [1 ]
机构：
[1] Yonsei Univ, Coll Med, Inst Vis Res, Dept Ophthalmol,Severance Hosp, Seoul, South Korea
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
547
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Ranibizumab for exudative age-related macular degeneration: 5 years follow-up dropout rate
    Boulanger-Scemama, Elise
    Querques, Giuseppe
    Puche, Nathalie
    Srour, Mayer
    Souied, Eric H.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [32] Long-term choroidal thickness changes based on the subtype of macular neovascularization in neovascular age-related macular degeneration (5-year follow-up)
    Abdin, Alaa Din
    Hanifa, Omar
    Aljundi, Wissam
    Munteanu, Cristian
    Seitz, Berthold
    Suffo, Shady
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (02) : 457 - 468
  • [33] Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab
    Zehetner, C.
    Kralinger, M. T.
    Kieselbach, G. F.
    SPEKTRUM DER AUGENHEILKUNDE, 2008, 22 (06) : 370 - 375
  • [34] Long-term choroidal thickness changes based on the subtype of macular neovascularization in neovascular age-related macular degeneration (5-year follow-up)
    Alaa Din Abdin
    Omar Hanifa
    Wissam Aljundi
    Cristian Munteanu
    Berthold Seitz
    Shady Suffo
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 457 - 468
  • [35] A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study
    Lalwani, Geeta A.
    Rosenfeld, Philip J.
    Fung, Anne E.
    Dubovy, Sander R.
    Michels, Stephen
    Feuer, William
    Davis, Janet L.
    Flynn, Harry W., Jr.
    Esquiabro, Maria
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2009, 148 (01) : 43 - 58
  • [36] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    Tan, C. S. H.
    EYE, 2011, 25 (10) : 1374 - 1374
  • [37] Bimonthly Ranibizumab for Neovascular Age-Related Macular Degeneration
    Cohen, Salomon Yves
    Maloberti, Bertrand
    Fajnkuchen, Franck
    Nghiem-Buffet, Sylvia
    Delahaye-Mazza, Corinne
    Grenet, Typhaine
    Quentel, Gabriel
    OPHTHALMOLOGICA, 2014, 231 (02) : 80 - 85
  • [38] Ranibizumab for neovascular age-related macular degeneration - Reply
    Rosenfeld, Philip J.
    Brown, David M.
    Schneider, Susan
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 749 - 750
  • [39] COMPARISON OF INTRAVITREAL BEVACIZUMAB FOLLOWED BY RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Stepien, Kimberly E.
    Rosenfeld, Philip J.
    Puliafito, Carmen A.
    Feuer, William
    Shi, Wei
    Al-Attar, Luma
    Dubovy, Sander R.
    Murray, Timothy G.
    Davis, Janet L.
    Lee, Wen-Hsiang
    Schwartz, Stephen G.
    Smiddy, William E.
    Berrocal, Audina M.
    Flynn, Harry W., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (08): : 1067 - 1073
  • [40] PROGNOSTIC FACTORS AND OUTCOME OF INTRAVITREAL RANIBIZUMAB TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Narayan, Daniel
    Meucke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2012, 40 : 113 - 113
12345